X

Pharmaceutical

Aarti Pharmalabs Ltd Q2FY25; 6% rise in Profits

Incorporated in 2019, Aarti Pharmalabs Ltd is a manufacturer of Pharmaceuticals and Nutraceuticals Financial Results: Aarti Pharmalabs Ltd reported Revenues…

ERIS Lifesciences Ltd Q2FY25; 21% fall in Profits

ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd…

Dr Reddys Laboratories Ltd Q2FY25; 9% fall in Profits

Dr. Reddy's Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active…

Sanofi India Ltd Q2FY25; 46% fall in Profits

Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of…

Asian Paints Ltd Q2FY25; 44% fall in Profits

AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products. Financial Results: Astrazeneca…

Natco Pharma Ltd Q2FY25; 83% rise in Profits

NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing…

Alkem Laboratories Ltd Q2FY25; 14% rise in Profits

Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale…

Alembic Pharmaceuticals Ltd Q2FY25; 12% rise in Profits

Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.…

Abbott India Ltd Q2FY25; 43% fall in Profits

Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors…

Glaxosmithkline Pharmaceuticals Ltd Q2FY25; 16% rise in Profits

GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people. Financial Results: Glaxosmithkline…